(NPC) is one of the few epithelial-origin tumors observed in pediatric population accounting for around 1-5% of all pediatric cancers and characterized with higher incidence of advanced loco-regional compromise. Aim of the work: to explore the impact of 18 F-FDG-PET/CT in pediatric nasopharyngeal carcinoma (PNPC) either during initial staging or restaging after end of therapy versus conventional imaging (CI) modalities (MRI and Ce-CT). Patients and methods: 40 patients with biopsy proven PNPC (mean age 13, SD ± 2.3; range 9-17) mostly of non-keratinizing undifferentiated type III (95%) were included in the study. Whole body 18 F-FDG-PET/CT, MRI and CE-CT of the head and neck were obtained in all patients, as well as MRI and CE-CT of the chest and the abdomen (the interval between the different modalities ranged from 2-28 days). The findings of PET/CT were compared with those of CI modalities regarding the TNM staging either initially or after end of therapy. Results: the studied group of patients was divided into two categories for analysis; 21 patients were analyzed at initial staging (52.5%) and 19 patients (47.5%) were analyzed for restaging after end of 1st line of therapy. In initial staging; The T stage detectability revealed a higher sensitivity for MRI versus PET/CT with sensitivity of 100% vs. 95.2% for PET/CT and MRI respectively. Regarding the N stage; PET/CT shows higher sensitivity than CI modalities with sensitivity values of 95.2% and 88.8% and 77.7% for PET/CT, MRI, and CT respectively. 18 In respect of the M stage; the sensitivity values were 80%, 60% and 25% for PET/CT, MRI, and CT respectively. In re-staging; PET/CT has higher sensitivity than CI modalities for local residual/recurrence (T), nodal (N) and distant metastases (M) with values of 100% vs. 86% in T stage, 100% vs. 91% in N stage and 100% vs. 66% in M stage for PET/CT and CI modalities respectively. Conclusion: 18 F-FDG-PET/CT is considered a potentially valuable imaging tool in PNPC either in initial staging or restaging which could effectively change the overall staging and hence the management.
INTRODUCTION:
Nasopharyngeal cancer (NPC) is an aggressive epithelial malignancy characterized with higher incidence of advanced loco-regional and distant compromise (1) . In Egypt, pharyngeal cancers account for 1.6% of all incident cancers yearly and NPC is considered the 2 nd most common in this entity with 32.8% incidence rate (2) . Pediatric nasopharyngeal carcinoma (PNPC) is a rare epithelialorigin tumor accounting for around 1-5% of all pediatric cancers and 10% of all nasopharyngeal cancers, with better outcome for children than for adults (3, 4) .
The treatment of NPC is based on the use of combined radio-and chemotherapy (5) , with similar treatment strategies in PNPC (3) and though their known inherent chemo-radio-sensitivity; around 13% of cases present with residual disease after the end of therapy (6) . The appropriate management strategy for NPC depends on proper staging using the TNM staging system (7) .
Clinical examination and naso-pharyngoscopy are not sufficient for this purpose (8) .
Imaging with Magnetic resonance imaging (MRI) and contrast enhanced computed tomography (CE-CT) scans are the commonly used anatomic conventional imaging (CI) techniques to assess tumor extent, and suspicious findings (9) . MRI is considered superior to CE-CT in staging NPC due to its high soft tissue resolution capabilities; however, it has its own limitations in the follow-up of these patients.
These limitations are mainly resulting from the effects of therapy and inability to differentiate tissue fibrosis from early residual or recurrent disease (10) .
Functional imaging using 18 F-FDG-PET/CT is considered a potential and promising imaging technique which can be used for accurate staging as well as followup of these patients with NPC (9) .
Aim of the study: to explore the potential 
Statistical analysis:
The following criteria were accepted as our standard of reference: 
RESULTS:
The studied group of patients (40 patients 
A. Analysis of 21 patients with PNPC presented for initial staging
The frequencies of TNM and overall staging in the three imaging modalities are summarized in tables (1 and 2). PPV: positive predictive value, NPV: negative predictive value. We grouped the studied patients (40 patients) into two categories according to the clinical indication of the study.
Category (1) initial staging: (21 patients) and Category (2) follow-up: (19 patients).
Category (1) initial staging:
We compared 18 F-FDG-PET/CT, MRI, and CT in the detection of primary site of PNPC (T status), the loco- In respect of M stage; our study showed that 18 F-FDG PET/CT interpretation reveals 4 patients (19%) with true positive distant metastases at initial presentation (M1), they were located in bone, liver and lung (2 patients) with 80% and 100% sensitivity and specificity respectively. 
